$2.385
+0.078 (+3.25%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
IKT 相似圖表分析預測
Alphio's IKT stock price prediction model matches the current Inhibikase Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.42 (+1.87%). The 1-week path is $2.42 (+1.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Inhibikase Therapeutics Inc 股票嗎？
Inhibikase Therapeutics Inc (IKT) is a good buy right now due to its recent earnings performance, where it reported a GAAP EPS of -$0.10, beating expectations of -$0.11, indicating improvements in operational efficiency. Additionally, the company has a strong cash position of $170.4 million, which supports ongoing R&D efforts. However, the main risk is its negative earnings trend, with a forward P/E of 0 and a projected loss of -$16.38 million in Q1 2026.
IKT 股價於 Tuesday 收在 $2.39，此前上漲 +3.25%
Inhibikase Therapeutics Inc (IKT) last closed at $2.38, gaining +3.03%. These facts feed the 1-day and 1-week IKT price prediction above.
預測驅動因素
Inhibikase Therapeutics Inc（IKT）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
相似圖表形態
近期走勢與 IKT 最接近的股票，依相似度排序。
IKT 季節性分析
Historically the probability of a positive September return for IKT is 16.67%. July offers the highest probability of a positive month at 57.58%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
IKT 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Sep 2026 | $1.67 | $1.99 | $2.18 | -16.46% |
| Oct 2026 | $1.54 | $1.81 | $1.95 | -23.74% |
| Nov 2026 | $1.50 | $1.64 | $1.87 | -31.00% |
| Dec 2026 | $2.07 | $2.22 | $2.41 | -6.65% |
2026 年，Inhibikase Therapeutics Inc（IKT）預計區間為 $1.50 至 $2.41。
Inhibikase Therapeutics Inc 2026 年月度預測
2026 年 Sep，Inhibikase Therapeutics Inc 預計均價 $1.99，最低 $1.67，最高 $2.18。
2026 年 Oct，Inhibikase Therapeutics Inc 預計均價 $1.81，最低 $1.54，最高 $1.95。
2026 年 Nov，Inhibikase Therapeutics Inc 預計均價 $1.64，最低 $1.50，最高 $1.87。
2026 年 Dec，Inhibikase Therapeutics Inc 預計均價 $2.22，最低 $2.07，最高 $2.41。
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。